A Phase I, Open Label, Drug-drug Interaction Study to Evaluate the Effects of Itraconazole and Rifampin on the Pharmacokinetics of ASC40 in Healthy Subjects
Latest Information Update: 16 Jul 2021
At a glance
- Drugs Denifanstat (Primary) ; Itraconazole; Rifampicin
- Indications Astrocytoma; Breast cancer; Colorectal cancer; Non-alcoholic steatohepatitis; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Ascletis
- 13 Jul 2021 Status changed from recruiting to completed.
- 15 Apr 2021 New trial record